EFMC-ISMC 2016

XXIV EFMC International Symposium on Medicinal Chemistry

 Manchester, UK    August 28

Committees


International Organising Committee

Symposium Chairman

Dr P. JONES

University of Dundee, Glasgow, United Kingdom

Members

Prof. M. ANDERLUH

University of Ljubljana, Ljubljana, Slovenia

Prof. K. AUGUSTYNS

University of Antwerp, Antwerp, Belgium

Dr K. BRINER

Novartis, Cambridge, United States

Prof. R. DEPREZ-POULAIN

University of Lille, Lille, France

Prof. M. P. GOYA LAZA

Instituto de Quimica Medic, CSIC, Madrid, Spain

Dr A. GRAVEN SAMS

H. Lundbeck, Valby, Denmark

Prof. R. MOREIRA

University of Lisbon, Lisbon, Portugal

Dr M. TOZER

Consultant, Cambridge, United Kingdom

Dr F. VON NUSSBAUM

Bayer Pharma, Berlin, Germany

Local Organising Committee

Chairman

Dr M. TOZER

Consultant, Cambridge, United Kingdom

Members

Dr S. BAGAL

AstraZeneca, Cambridge, United Kingdom

Prof. S. CONWAY

University of Oxford, Oxford, United Kingdom

Dr P. JONES

University of Dundee, Glasgow, United Kingdom

Dr A. JORDAN

Cancer Research UK Manchester Institute, Manchester, United Kingdom

Dr A. J. RATCLIFFE

Redx Anti-infectives Ltd, Alderley Edge, United Kingdom

Prof. M. WARING

University of Newcastle, Newcastle upon Tyne, United Kingdom

Dr D. WITTY

Convergence Pharmaceuticals, United Kingdom

International Scientific Committee

Members

Prof. M. AMBLARD

CNRS-Universty of Montpellier I, Montpellier, France

Prof. A. BECK-SICKINGER

Leipzig University, Leipzig, Germany

Dr C. BOSS

Actelion Pharmaceuticals Ltd, Allschwil, Switzerland

Dr A. BROWN

Stratified Medical, Deal, United Kingdom

Dr J. BURROWS

Medicines for Malaria Venture (MMV), Geneva, Switzerland

Dr T. CALOGEROPOULOU

National Hellenic Research Foundation, Athens, Greece

Dr N. CARRUTHERS

Johnson & Johnson R&D, San Diego, United States

Dr B. CEZANNE

Merck, Darmstadt, Germany

Prof. K. CHIBALE

University of Cape Town, Cape Town, South Africa

Dr M. COGHLAN

Eli Lilly and Company, Indianapolis, Indiana, United States

Prof. G. COSTANTINO

University of Parma, Parma, Italy

Prof. B. COX

University of Sussex, Brighton, United Kingdom

Dr W. CZECHTIZKY

Sanofi, Mölndal, Sweden

Dr H. DOLLINGER

Boehringer Ingelheim Pharma, Biberach, Germany

Dr G. G. FERENCZY

Research Centre for Natural Sciences, Hungarian Academy of Sciences, Budapest, Hungary

Prof. B. FISCHER

Bar-Ilan University, Ramat-Gan, Israel

Prof. S. GOBEC

University of Ljubljana, Ljubljana, Slovenia

Dr E. GOMEZ

ALMIRALL, BARCELONA, Spain

Dr S. HADIDA

Vertex Pharmaceuticals, San Diego, United States

Dr A. HALL

UCB Pharma S.A., Braine-l'Alleud, Belgium

Dr L. HEITMAN

University of Leiden, Leiden, The Netherlands

Prof. K. JOZWIAK

Medical University of Lublin, Lublin, Poland

Prof. I. KALVINS

Latvian Institute of Organic Synthesis, Riga, Latvia

Prof. A. KARLÉN

Uppsala University, Uppsala, Sweden

Prof. S. KNAPP

Oxford University, Oxford, United Kingdom

Dr S. KOSTRUN

Fidelta Ltd, Zagreb, Croatia

Dr M. LEMURELL

AstraZeneca, Gothenburg, Sweden

Prof. A. MARTINEZ

Instituto de Quimica Medica-CSIC, Madrid, Spain

Prof. N. MAULIDE

University of Vienna, Vienna, Austria

Dr L. MEERPOEL

Janssen R&D, Beerse, Belgium

Dr C. MENET

Confo Therapeutics, Brussels, Belgium

Prof. A. MESSEGUER

IQAC-CSIC, Barcelona, Spain

Dr P. MOLENVELD

Mercachem-Syncom, Nijmegen, The Netherlands

Prof. C. MONTANARI

University of Sao Paulo, Sao Paulo, Brazil

Dr V. MOREIRA

Faculty of Pharmacy, University of Helsinki, Helsinki, Finland

Dr S. F. NIELSEN

LEO Pharma, Ballerup, Denmark

Dr U. OBST-SANDER

F.Hoffmann - La Roche, BASEL, Switzerland

Prof. Z. PAN

Peking University, Shenzhen, China

Prof. R. PELLICCIARI

TES Pharma srl, Corciano, Italy

Prof. M. PINTO

Faculty of Pharmacy, University of Porto, Porto, Portugal

Prof. V. POROIKOV

Institute of Biomedical Chemistry, Moscow, Russia

Dr P. RATCLIFFE

Grünenthal, Aachen, Germany

Dr D. REES

Astex Pharmaceuticals, Cambridge, United Kingdom

Dr M. ROWLEY

Merck Research Laboratories, Kriens, Switzerland

Prof. P. H. SEEBERGER

Max Planck Institute of Colloids and Interfaces, Berlin, Germany

Prof. H. U. STILZ

Novo Nordisk, Malov, Denmark

Prof. K. STROMGAARD

University of Copenhagen, Copenhagen, Denmark

Prof. H. SUGA

University of Tokyo, Tokyo, Japan

Prof. E. TATE

Imperial College London, London, United Kingdom

Prof. H. TIMMERMAN

VU University Amsterdam, Oegstgeest, The Netherlands

Prof. M. TODD

University of Sydney, London, United Kingdom

Dr A. TORRENS

Esteve Pharmaceuticals, Barcelona, Spain

Prof. N. J. TURNER

University of Manchester, Manchester, United Kingdom

Dr L. VAN HIJFTE

SCT & NovAliX, Nijmegen, The Netherlands

Dr M. VARASI

European Institute of Oncology, Milano, Italy

Dr J. VELCICKY

Novartis Institutes for Biomedical Research, Basel, Switzerland

Dr V. . VELJKOVIC

Vinča Institute of Nuclear Sciences, Belgrade, Serbia

Dr M.-Q. ZHANG

Amgen China, Shanghai, China